Dr. Paulo A. Garcia co-invented the Flowfect® technology while he was a Research Scientist at MIT. He is currently leading the development and commercialization efforts of the proprietary cell engineering platform for therapeutic and biotechnology applications.

Cullen R. Buie, Ph.D. is a Tenured Professor of Mechanical Engineering at MIT and co-inventor of the high-throughput genetic modification technology. He brings expertise in the areas of microfluidics, microfabrication, and experimental fluid mechanics to Kytopen.

Bethany has focused her career on bringing innovative medical device solutions to market. She led concepts through launch and acquisition, and directed innovation and product development at J&J. She graduated from MIT with a B.S. and M.S. in Aeronautical and Astronautical Engineering.

As a seasoned business leader, Greg has spent his career leading teams of sales, marketing, product development and operations professionals in commercializing innovative tools and technologies for advancing the development and manufacturing of Biopharmaceuticals with key industry suppliers including Cytiva/GE Healthcare, BD, Pall and Merck Millipore.

Ta-Chun Hang has worked in early development through commercial manufacturing for biologics and cell therapies, including supporting regulatory activities as well as heading pilot plant operations. He has combined his breadth of knowledge and expertise to drive innovation and novel approaches in process development. Ta-Chun completed two bachelor’s degrees (Biomedical Engineering, Human Physiology) from the University of Minnesota and a PhD in Biological Engineering from MIT.

John Zhao graduated from Cornell with a B.S. in Bioengineering and University of Louisville with a M.S. in Biochemistry. His career has been dedicated to cell therapy in various roles including research, development and manufacturing. His primary focus is innovative process development techniques and applications.

Michael is an accomplished executive in Operations and P&L Management. Managed various manufacturing and operational functions at BD in Diagnostics, Medical Devices, and Biosciences. More recently, led activities for emerging Biotech firms to hyper-scale their business and operational models globally. Michael holds a B.S. in Mechanical Engineering, from BYU, and an MBA, from MIT Sloan.

Verona is an accomplished Quality professional with extensive experience in regulatory compliance and quality management systems supporting pharmaceutical development and market approval. Her background includes regulatory compliance and inspection readiness, business development, laboratory operations, pharmaceutical research, and education. Verona graduated from the University of Massachusetts Boston with a B.S and M.S. in Chemistry.

Michael Baladiang, B.S. graduated from the University of Massachusetts Amherst with a degree in biology. He has experience doing work in immunology specifically with efforts in HIV and more recently COVID and focused on optimization and automation of laboratory procedures.

Eduardo is a hands-on technical leader and collaborator tackling complex problems. He has experience leading diverse technical teams in the medical technology space. Eduardo studied Engineering Mechanics (M.S.) and Mechanical Engineering (B.S.) at Virginia Tech.

Norman has made a career of bringing novel science and technology from research to reality. Previously, he was at Emulate, where he helped lead the buildout of its core technology and business to be a leader in the Organs-on-Chips and advanced in vitro model space. Norman graduated from University of California Berkeley with degrees in Mechanical Engineering B.S. and Materials Science B.S.

Ross Beighley, B.S. graduated from Tufts University where he studied Computer Engineering and Biomedical Engineering. His professional experience centers on transitioning benchtop solutions to worldwide markets through automation.

Gretchen has spent much of her career understanding the use of hematopoietic stem cells in the treatment of genetic diseases, with a focus on early preclinical research. She joins Kytopen from bluebird bio, and holds a B.S. from the University of Massachusetts at Lowell.

Andrew Hallinan graduated from the University of Massachusetts Amherst with a B.S. in Chemical Engineering. His previous research experience primarily focused on translational biomaterials and tissue engineering within the bone marrow niche.

Rameech McCormack, M.S. master’s graduate from the Mechanical Engineering Department at MIT. He is also a co-inventor of the high throughput Flowfect® technology. Rameech leads the effort in product manufacturing, design, and integration.

Maham Zia is currently pursuing an M.S. in Computer Science at Northeastern University. She graduated with a B.S. in Political Science from Northeastern University where she discovered a love for problem solving. She is interested in exploring the various applications of computer science while developing her coding skills.